Johnson & Johnson
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson Asia Pacific employees by Year
Johnson & Johnson Asia Pacific employees: 23,744 in FY2025, down 2.9% from a year earlier.
Latest, FY2025
23,744
Period ended Dec 28, 2025
Change on a year earlier
-2.9%
24,445 in FY2024
History
3 years
Since FY2023
Sources
1
J&J 2025 Health for Humanity Report
Where the FY2025 figure comes from
“Asia Pacific 23,744 24,445 24,378”
Source: J&J 2025 Health for Humanity Report ↗
Reported in 2025 Health for Humanity Report.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Asia Pacific employees | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 23,744 | -2.9% | J&J 2025 Health for Humanity Report ↗ |
| FY2024 | Dec 29, 2024 | 24,445 | +0.3% | J&J 2025 Health for Humanity Report ↗ |
| FY2023 | Dec 31, 2023 | 24,378 | – | J&J 2025 Health for Humanity Report ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Asia Pacific employees, annual FY2023–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/esg-emp-apac
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.